-
Dow 30 Profile: Johnson & Johnson
Since its founding about 125 years ago, Johnson & Johnson (JNJ) has become the world’s largest and most broadly based health care company through mergers, acquisitions, and internal growth.
...Read more -
Dow 30 Earnings: American Express - Second Quarter 2012
American Express (AXP) has reported healthy second-quarter financial results. The top-line advance mostly stemmed from continued growth in cardmember spending (albeit at a somewhat slower rate than investors have become accustomed to), as well as greater net interest income.
...Read more
-
Dow 30 Profile: UnitedHealth Group
UnitedHealth Group (UNH) will be taking the place of Kraft Foods in the Dow 30 effective September 24, 2012. We take a look at the company’s beginnings and its evolution into the healthcare titan it is today.
...Read more
Analyst Corner: Dow 30
-
Stock Market Today: February 1, 2013
February 01, 2013 -
Major indexes were up big today, continuing the bull-run that was in p...
-
Stock Market Today: January 28, 2013
January 28, 2013 -
The U.S. equity indexes lacked direction during today...
-
Carbon Fiber’s Move into the Mainstream
February 07, 2013 -
Manufacturing processes for carbon fiber comp...
-
Using the Value Line Page: Merck vs. Pfizer vs. Johnson & Johnson
February 07, 2013 -
Comprised of a broad range of stocks within different industries, the<...
-
Dow-30 Earnings: The Walt Disney Company - First Quarter Fiscal 2013
February 06, 2013 -
Entertainment giant and Dow-30 component The ...
-
Dow-30 Earnings: Exxon Mobil - Fourth Quarter 2012
February 01, 2013 -
Oil giant Exxon Mobil (XOM) closed out 2012 with stro...
-
Dow-30 Earnings: Chevron Corp. - Fourth Quarter 2012
February 01, 2013 -
Oil giant and Dow-30 component Chevron (CVX) ...
-
Dow-30 Earnings: Merck & Co. - Fourth Quarter 2012
February 01, 2013 -
Drugmaker and Dow-30 component Merck & Co...
-
Dow-30 Earnings: Boeing - Fourth Quarter 2012
January 30, 2013 -
Aerospace and defense giant Boeing (BA) has released ...
-
Dow-30 Earnings: Pfizer - Fourth Quarter 2012
January 29, 2013 -
Drugmaker Pfizer (PFE) continues to deal with the det...



